Literature DB >> 7287870

Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin.

P G Whittaker, T Wilcox, T Lind.   

Abstract

The heterogeneity of serum PRL in a hyperprolactinemic but fertile woman (Patient A) was studied by gel chromatography. Ninety percent of her PRL eluted with the void volume as "big, big" PRL and only 6% coincided with monomeric "little" PRL. Sera from a woman who had hyperprolactinemia associated with infertility (Patient B) and a normal woman (Patient C) exhibited the usual heterogeneous distribution, where 5% and 19%, respectively, eluted as big, big PRL and 76% and 65%, respectively, eluted as little PRL. Serial dilutions of the serum from Patient A displayed nonparallelism to the lines obtained from similar dilutions of both PRL standard and serum from a normal woman, suggesting possible immunological differences among the three forms of the circulating hormone. This finding, together with reports that suggest big, big PRL has a low receptor affinity, may account for the apparent lack of any biological effect upon Patient A from her sustained hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287870     DOI: 10.1210/jcem-53-4-863

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia.

Authors:  H Tamai; O Mizuno; A Takaki; K Kiyohara; G Komaki; S Matsubayashi; K Kuma; L F Kumagai; S Nagataki
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

2.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

3.  Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.

Authors:  B Cavaco; S Prazeres; M A Santos; L G Sobrinho; V Leite
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

5.  Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.

Authors:  M Guitelman; M E Colombani-Vidal; C C Zylbersztein; L Fiszlejder; M Zeller; O Levalle; H E Scaglia
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

6.  Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.

Authors:  M E Fonseca; R Ochoa; C Morán; A Zárate
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

Review 7.  The risks of overlooking the diagnosis of secreting pituitary adenomas.

Authors:  Thierry Brue; Frederic Castinetti
Journal:  Orphanet J Rare Dis       Date:  2016-10-06       Impact factor: 4.123

8.  Macroprolactinemia and Empty Sella Syndrome.

Authors:  Ach Taieb; Kacem Njah Maha; Yosra Hasni El Abed; Amel Maaroufi Beizig; Molka Chaieb Chadli; Koussay Ach
Journal:  Pan Afr Med J       Date:  2017-08-14

9.  Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice.

Authors:  Vaishya Richa; Gupta Rahul; Arora Sarika
Journal:  J Reprod Infertil       Date:  2010-10

Review 10.  Macroprolactinemia: new insights in hyperprolactinemia.

Authors:  Miro Kasum; Slavko Oreskovic; Ivana Zec; Davor Jezek; Vlatka Tomic; Vesna Gall; Goran Adzic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.